A Placebo Controlled Trial of Acebilustat (CTX 4430) for the Treatment of Human Upper Extremity Lymphedema

Clinical trial NCT05203835 · COMPLETED

Trial details

NCT number: NCT05203835
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphedema of Upper Arm

Start date: 2022-07-27
Primary completion: 2025-10-21
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.